Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

19.80
Delayed Data
As of Feb 22
 -0.29 / -1.44%
Today’s Change
10.85
Today|||52-Week Range
36.69
+4.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues20.3B19.6B22.0B22.5B
 
 
 
 
 
Cost of Goods Sold7.7B7.0B8.5B9.6B
 
 
 
 
 
Depreciation And Amortization1.5B1.3B1.5B2.1B
 
 
 
 
 
 
Operating ExpensesGross Income11.1B11.3B11.9B10.9B
 
 
 
 
 
General Expenses6.6B6.2B7.2B6.9B
 
 
 
 
 
Other Operating Expenses0.000.000.0083.6M
 
 
Research And Development1.5B1.5B2.1B1.9B
 
 
 
 
 
Total Operating Expenses15.8B14.5B17.3B18.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.5B5.1B4.7B3.9B
 
 
 
 
 
Extraordinary Credit237.0M53.0M--96.7M
 
 
 
 
Extraordinary Charge-633.0M-2.4B-3.3B-22.4B
 
 
 
 
 
Interest Expense On Debt435.0M464.8M692.2M805.7M
 
 
 
 
 
Equity In Earnings-5.0M-121.0M8.0M-3.0M
 
 
 
 
 
Other Expenses-47.0M60.0M88.3M595.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.6B2.4B826.6M-18.5B
 
 
 
 
 
Income Taxes-591.0M-633.8M-522.6M-1.9B
 
 
 
 
 
Minority Interest-13.0M-9.0M-18.1M-185.3M
 
 
 
 
 
Preferred Dividend0.00-15.0M-261.8M-261.8M
 
 
 
 
Net Income3.1B1.6B330.0M-16.4B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS853.0M855.0M955.0M1.0B
 
 
 
 
 
Shares To Calculate EPS Diluted858.0M864.0M961.0M1.0B
 
 
 
 
 
 
Earnings Per ShareEPS$3.58$1.84$0.07-$16.38
 
 
 
 
 
EPS Diluted$3.56$1.82$0.07-$16.38